secwatch.observer — SEC 8-K summary
======================================

Issuer:     Streamex Corp. (STEX)
CIK:        0001530766
Form:       8-K
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0001493152-24-010175
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioSig receives Nasdaq delisting notice for being a public shell; appeal hearing May 7
--------------------------------------------------------------------------------

- Nasdaq Staff determined BioSig is a 'public shell' with no operating business, citing recent workforce reduction (16 employees, exec resignations) and now one employee and one board member.
- Company also fails minimum $35M Market Value of Listed Securities requirement under Rule 5550(b)(2).
- BioSig had already failed minimum bid price rule and cannot get a second cure period due to insufficient stockholders' equity.
- Hearing before Nasdaq Hearings Panel scheduled for May 7, 2024; company intends to appeal the additional delisting basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1530766/000149315224010175/0001493152-24-010175-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1530766/000149315224010175/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-010175

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer